Your browser doesn't support javascript.
loading
Targeting metabolism to overcome cancer drug resistance: A promising therapeutic strategy for diffuse large B cell lymphoma.
Pi, Manfei; Kuang, Huixian; Yue, Chunyan; Yang, Qixuan; Wu, Anqin; Li, Yuhua; Assaraf, Yehuda G; Yang, Dong-Hua; Wu, Shaojie.
Afiliación
  • Pi M; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Kuang H; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Yue C; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Yang Q; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Wu A; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Li Y; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Assaraf YG; The Fred Wyszkowski Cancer Research Lab, Technion - Israel Institute of Technology, Haifa, Israel.
  • Yang DH; College of Pharmacy and Health Sciences, St. John's University, New York, NY, United States. Electronic address: Yangd1@stjohns.edu.
  • Wu S; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China. Electronic address: wshj510515@163.com.
Drug Resist Updat ; 61: 100822, 2022 03.
Article en En | MEDLINE | ID: mdl-35257981
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Resistencia a Antineoplásicos Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Resistencia a Antineoplásicos Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article